Los Angeles Capital Management
ANAC

Los Angeles Capital Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Los Angeles Capital Management’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,834
Closed -$216K – 1249
2015
Q3 		$216K Buy
+1,834
New +$240K ﹤0.01% 1097
2015
Q2 		– Sell
-6,695
Closed -$387K – 1313
2015
Q1 		$387K Buy
6,695
+40
+0.6% +$1.7K ﹤0.01% 995
2014
Q4 		$215K Buy
+6,655
New +$200K ﹤0.01% 1049

Other funds holding ANAC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Los Angeles Capital Management's ANAC Position: Q4 2015 in Review

Los Angeles Capital Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q4 2015, closing a stake of 1,834 shares — an estimated $216K sold.

Los Angeles Capital Management first reported a position in ANAC in Q4 2014 and held it in 3 quarters. The position peaked at $387K in Q1 2015. 214 funds tracked by Wall St. Rank hold ANAC as of Q4 2015.

  • Los Angeles Capital Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q4 2015 after selling out during the quarter.
  • Los Angeles Capital Management sold 1,834 ANACOR PHARMACEUTICALS INC COM shares in Q4 2015, an estimated $216K.
  • Los Angeles Capital Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 3 quarters.
  • Los Angeles Capital Management's ANACOR PHARMACEUTICALS INC COM position peaked at $387K in Q1 2015.
  • 214 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q4 2015.

Based on Los Angeles Capital Management's 13F filing for Q4 2015, filed 9 Feb 2016.